Analyst Ratings for Regulus Therapeutics (RGLS)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.7 / 10
Percentile Rank: 22%
Rating Score: 2.7 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2025 | Leerink Partners | Joseph Schwartz | Downgrade | Market Perform (Outperform) |
7.00 (6.00) |
3.37 (8.16) |
142.14% | Details |
| 4/30/2025 | Oppenheimer | Andreas Argyrudes | Downgrade | Perform (Outperform) |
N/A (N/A) |
3.37 (8.16) |
142.14% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


